KAT6A and acute myeloid leukemia: Through rapid immunoprecipitation mass spectrometry of endogenous proteins, interaction between NUP98 fusion oncoprotein and MYST HAT complexes, including KAT6A and KAT6B, was observed in eight preclinical models of NUP98‐rearranged AML.